Table 3.
Chromosome19q13.13.1–13.2.
| AD-association | ||
|---|---|---|
| APOE4/q13.31 | APOE4 associated more with apoB lipoproteins | Roses et al. (2010) and Kulminski et al. (2019) |
| APOC1/q13.32 | Inhibits CETP; all lipoprotein particles VLDL; | Kulminski et al. (2019) and Zhou et al. (2019) |
| APOEC1P/q13.32 | Pseudogene | Kulminski et al. (2019) |
| APOC2/q13.32 | activates LP lipase for triglyceride hydrolysis | Kulminski et al. (2019) |
| APOC4/q13.32 | VLDL | Kulminski et al. (2019) |
| BCAM/q13.32 | basal cell adhesion molecule | Kulminski et al. (2019) |
| BCL3/Q13.32 | B cell leukemia protein 3, transcription factor | Kulminski et al. (2019) |
| CGB/q13.32 | chorionic gonadotrophin | |
| CLPTM1/q13.32 | cleft lip and palate transmembrane factor 1 | Kulminski et al. (2019) |
| CYP2A/q13.2 | cytochrome P450 | |
| C5aR1/q13.3–13.4 | complement factor 5a receptor 1 | |
| FOXA3/q13.2–13.4 | forkhead box transcription factor | |
| IGFL1–4/q13.32 | IGF-like family | |
| IRF2BP1/q13.32 | Interferon regulatory factor 2-binding protein 1, cotranscription factor | |
| LHB/q13.32 | luteinizing hormone beta peptide | |
| NECTIN2/q13.32 | herpes receptor (HHV-1); also PVRLl2 | Kulminski et al. (2019) and Zhou et al. (2019) |
| NTF4/q13.3 | neurotrophin | |
| OPA3/q13.32 | outer mitochondrial membrane | |
| PVRL2/q13.32 | poliovirus, receptor-related protein; nectin 2 | Kulminski et al. (2019) and Zhou et al. (2019) |
| RELB/q13.32 | NFkB subunit, transcription factor | |
| TOMM40/q13.32 | translocase of outer mitochondrial membrane 40 kDa | Roses et al. (2010) and Kulminski et al. (2019) |
| TGFβ1/q13.2 | Transforming growth factor β1 | |
| ZNF/q13.2 | Zinc finger transcription factors, > 20 |